The Neurology Advisor Team spoke with Tracy Bedrosian, PhD at AES 2025 in Atlanta, Georgia. Neurology Advisor: “Can you describe your work in the epilepsy space?” ...
The FDA is facing even more leadership changes as drug regulator Dr Richard Pazdur prepares to retire at the end of the month.
Immediate neuro-rehabilitative treatment following moderate or severe TBI is associated with reduced risk of Alzheimer disease.
Impaired kidney function is associated with increased circulating levels of most Alzheimer disease blood biomarkers.
Tai chi is an effective alternative approach for the long-term management of chronic insomnia in middle-aged and older adults.
The Food and Drug Administration has granted Breakthrough Therapy designation to zilganersen for the treatment of Alexander disease.
Cancer related cognitive impairment in patients can stem from the cancer itself as well as the therapies used to treat it.
The FDA has approved Avance® (acellular nerve allograft-arwx) for the treatment of sensory nerve discontinuity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback